SMTL ID : 8bhb.1

GABA-A receptor a5 homomer - a5V3 - RO154513

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

homo-pentamer

Ligands

5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 4 residues within 4Å: Chain A: N.167, T.203, E.204, N.205 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.167 NAG.3: 4 residues within 4Å: Chain B: N.167, T.203, E.204, N.205 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:N.167 NAG.5: 4 residues within 4Å: Chain C: N.167, T.203, E.204, N.205 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:N.167 NAG.7: 4 residues within 4Å: Chain D: N.167, T.203, E.204, N.205 1 PLIP interactions: 1 interactions with chain D Hydrogen bonds: D:N.167 NAG.9: 4 residues within 4Å: Chain E: N.167, T.203, E.204, N.205 1 PLIP interactions: 1 interactions with chain E Hydrogen bonds: E:N.167

5 x EIE: ethyl 8-[(azanylidene-$l^{4}-azanylidene)amino]-5-methyl-6-oxidanylidene-4~{H}-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate(Non-covalent)

EIE.2: 18 residues within 4Å: Chain A: F.103, H.105, G.161, S.162, Y.163, I.206, T.208, S.209, T.210, Y.213, I.215 Chain E: D.47, M.48, Y.49, F.68, A.70, M.121, T.133 5 PLIP interactions: 4 interactions with chain A, 1 interactions with chain E Hydrophobic interactions: A:F.103, A:I.206, E:Y.49 Hydrogen bonds: A:G.161 pi-Stacking: A:Y.213 EIE.4: 18 residues within 4Å: Chain A: D.47, M.48, Y.49, F.68, A.70, M.121, T.133 Chain B: F.103, H.105, G.161, S.162, Y.163, I.206, T.208, S.209, T.210, Y.213, I.215 5 PLIP interactions: 1 interactions with chain A, 4 interactions with chain B Hydrophobic interactions: A:Y.49, B:F.103, B:I.206 Hydrogen bonds: B:G.161 pi-Stacking: B:Y.213 EIE.6: 18 residues within 4Å: Chain B: D.47, M.48, Y.49, F.68, A.70, M.121, T.133 Chain C: F.103, H.105, G.161, S.162, Y.163, I.206, T.208, S.209, T.210, Y.213, I.215 4 PLIP interactions: 3 interactions with chain C, 1 interactions with chain B Hydrophobic interactions: C:F.103, C:I.206, B:Y.49 pi-Stacking: C:Y.213 EIE.8: 18 residues within 4Å: Chain C: D.47, M.48, Y.49, F.68, A.70, M.121, T.133 Chain D: F.103, H.105, G.161, S.162, Y.163, I.206, T.208, S.209, T.210, Y.213, I.215 4 PLIP interactions: 3 interactions with chain D, 1 interactions with chain C Hydrophobic interactions: D:F.103, D:I.206, C:Y.49 pi-Stacking: D:Y.213 EIE.10: 18 residues within 4Å: Chain D: D.47, M.48, Y.49, F.68, A.70, M.121, T.133 Chain E: F.103, H.105, G.161, S.162, Y.163, I.206, T.208, S.209, T.210, Y.213, I.215 4 PLIP interactions: 3 interactions with chain E, 1 interactions with chain D Hydrophobic interactions: E:F.103, E:I.206, D:Y.49 pi-Stacking: E:Y.213

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kasaragod, V.B. et al., The molecular basis of drug selectivity for alpha 5 subunit-containing GABA A receptors. Nat.Struct.Mol.Biol. (2023)

Release Date

2023-11-01

Peptides

Gamma-aminobutyric acid receptor subunit alpha-5: ABCDE

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

E
E

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Gamma-aminobutyric acid receptor subunit alpha-5

Related Entries With Identical Sequence